Tabor Jr, Regies C.

HRN: 26-39-79  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/07/2025
03/13/2025
IV
500mg
Q6
Pcap
Waiting Final Action 
03/09/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
03/09/2025
03/15/2025
ORAL
3.5ml
Q12
PCAP-C
Waiting Final Action 
03/10/2025
MUPIROCIN 2%, 15G (TUBE)
03/10/2025
03/16/2025
TOPICAL
2%
BID
IV Site Inflammation
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: